Modular Assembly of Lipid Nanoparticles for Targeted mRNA Therapeutics and Vaccines
Advanced Materials · 2026
DOI: 10.1002/adma.202509199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Hu Xu und 17 weiteren Autor:innen. Beteiligte Einrichtung: College of Ecology, Lanzhou University, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Lipids, Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Targeted mRNA delivery remains a key challenge for lipid nanoparticles (LNPs), as existing surface functionalization strategies often suffer from uncontrolled cross‐linking, aggregation, and immunogenicity. Conventional tetrameric streptavidin‐biotin coupling, while biochemically robust, has limited translational potential due to its multivalency and poor structural control. Here, a monomeric streptavidin (mSA)‐based modular assembly platform is presented that enables rapid, stable, and customizable functionalization of LNPs. The monovalent design of mSA prevents aggregation and significantly reduces immunogenicity compared with conventional streptavidin. By fusing mSA to Fc‐binding domains (Z and C), universal linkers are created that can directly bind unmodified commercial antibodies, allowing plug‐and‐play construction of targeted LNPs without chemical modification. This approach supports interchangeable antigen or antibody labeling, yielding monodisperse and reproducible nanoparticles. Demonstrated across diverse therapeutic contexts—including virus‐like nanoparticle vaccines, tumor‐targeted mRNA therapy, and efficient transfection of primary mouse T cells (up to 98%)—the platform offers a generalizable and clinically adaptable strategy for precise mRNA delivery and vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Ecology, Lanzhou University, Lanzhou, 730000, China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Chinese Academy of Sciences, Beijing, 100190, China.
- Center for Pan-third Pole Environment, Lanzhou University, Lanzhou, 730000, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 100071, China.
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029, China.
ORCID-Profile: Hu Xu, Yuhong Cao
Förderung
- National Key Research and Development Program of China
- Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Xu, H., Li, T., Li, M., Zhang, J., Zhang, Z., Weng, Y., Luo, D., Yang, C., Guo, J., Liu, Y., Zhang, Y., Zhang, J., Sun, K., Qi, J., Wang, D., Gao, G. F., Zhao, G., & Cao, Y. (2026). Modular Assembly of Lipid Nanoparticles for Targeted mRNA Therapeutics and Vaccines. Advanced Materials. https://doi.org/10.1002/adma.202509199
Vancouver
Xu H, Li T, Li M, Zhang J, Zhang Z, Weng Y, et al. Modular Assembly of Lipid Nanoparticles for Targeted mRNA Therapeutics and Vaccines. Advanced Materials. 2026. doi:10.1002/adma.202509199
BibTeX
@article{Xu2026,
author = {Xu, Hu and Li, Tianyao and Li, Min and Zhang, Jingxin and Zhang, Ziwei and Weng, Yi and Luo, Dengwang and Yang, Chao and Guo, Jing and Liu, Yongqin and Zhang, Yue and Zhang, Jun and Sun, Keyu and Qi, Jianxun and Wang, Daming and Gao, George F and Zhao, Guangyu and Cao, Yuhong},
title = {Modular Assembly of Lipid Nanoparticles for Targeted mRNA Therapeutics and Vaccines},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202509199}
}
EUVIMED